Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for moderate-to-severe obstructive sleep apnea with low arousal threshold
TCTR20210217004Phase 2Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Oct 2024; status: completed.
02
Drugs
lemborexant
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on TCTR20210217004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210217004.